Akorn Newswire

Akorn Newswire

Comprehensive Real-Time News Feed for Akorn.

Results 1 - 20 of 675 in Akorn

  1. Akorn Inc. (AKRX) Shares Gap Up to $31.80Read the original story w/Photo

    Saturday | Daily Political

    Akorn Inc. 's share price gapped up prior to trading on Thursday . The stock had previously closed at $31.68, but opened at $31.80.

    Comment?

  2. Akorn Inc. (NASDAQ:AKRX) Receives Consensus Recommendation of "Buy" from BrokeragesRead the original story w/Photo

    Saturday | Daily Political

    Shares of Akorn Inc. have been given a consensus recommendation of "Buy" by the seventeen research firms that are currently covering the stock. One analyst has rated the stock with a sell rating, four have issued a hold rating and ten have issued a buy rating on the company.

    Comment?

  3. Akorn Inc. (AKRX) Stake Decreased by Pictet Asset Management Ltd.Read the original story w/Photo

    Friday Jul 22 | Daily Political

    Pictet Asset Management Ltd. decreased its stake in Akorn Inc. by 18.2% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 32,300 shares of the company's stock after selling 7,200 shares during the period.

    Comment?

  4. Akorn Inc. (AKRX) Shares Up 3.9%Read the original story w/Photo

    Friday Jul 22 | Daily Political

    Akorn Inc. traded up 3.9% during mid-day trading on Wednesday . The company traded as high as $31.66 and last traded at $31.52, with a volume of 495,094 shares traded.

    Comment?

  5. Akorn Inc. (AKRX) Shares Gap Up to $31.80Read the original story w/Photo

    Thursday Jul 21 | Daily Political

    Shares of Akorn Inc. gapped up before the market opened on Thursday . The stock had previously closed at $31.68, but opened at $31.80.

    Comment?

  6. Zacks Investment Research Downgrades Akorn Inc. (AKRX) to Strong SellRead the original story w/Photo

    Thursday Jul 21 | Daily Political

    According to Zacks, "Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. They also market ophthalmic surgical instruments and related products.

    Comment?

  7. Akorn Announces Second Quarter 2016 Earnings Release and Conference Call InformationRead the original story

    Thursday Jul 21 | P&T Community

    Akorn, Inc. , a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release on Thursday, August 4, 2016 outlining the second quarter 2016 results. In addition, the Company will host a conference call at 10:00 am EDT on the same day to discuss its second quarter 2016 financial results.

    Comment?

  8. Akorn Inc. (AKRX) Trading 3.9% HigherRead the original story w/Photo

    Wednesday Jul 20 | Daily Political

    Akorn Inc. 's share price traded up 3.9% during mid-day trading on Wednesday . The stock traded as high as $31.66 and last traded at $31.52, with a volume of 495,094 shares trading hands.

    Comment?

  9. Akorn Inc. (AKRX) Sees Unusually-High Trading VolumeRead the original story w/Photo

    Tuesday Jul 19 | Daily Political

    Shares of Akorn Inc. saw strong trading volume on Tuesday . 1,077,622 shares changed hands during trading, a decline of 20% from the previous session's volume of 1,352,437 shares.The stock last traded at $30.66 and had previously closed at $31.36.

    Comment?

  10. Akorn Inc. (AKRX) Lowered to Strong Sell at Zacks Investment ResearchRead the original story w/Photo

    Tuesday Jul 19 | AmericanBankingNews.com

    According to Zacks, "Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. They also market ophthalmic surgical instruments and related products.

    Comment?

  11. Zacks Investment Research Lowers Akorn Inc. (AKRX) to Strong SellRead the original story w/Photo

    Tuesday Jul 19 | AmericanBankingNews.com

    According to Zacks, "Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. They also market ophthalmic surgical instruments and related products.

    Comment?

  12. Akorn's (AKRX) "Outperform" Rating Reaffirmed at RBC Capital MarketsRead the original story w/Photo

    Tuesday Jul 19 | AmericanBankingNews.com

    ... RBC Capital Markets' price objective indicates a potential upside of 21.91% from the stock's current price. In other Akorn news, Director Kenneth Abramowitz sold 14,675 shares of the stock in a transaction on Friday, June 10th. The stock was sold at ...

    Comment?

  13. Akorn Inc. (AKRX) Given "Outperform" Rating at RBC Capital MarketsRead the original story w/Photo

    Tuesday Jul 19 | AmericanBankingNews.com

    ... RBC Capital Markets' price target points to a potential upside of 21.91% from the company's previous close. In other Akorn news, COO Bruce Kutinsky sold 142,000 shares of the company's stock in a transaction that occurred on Thursday, June 9th. The ...

    Comment?

  14. Akorn Inc. (AKRX) Given "Buy" Rating at Royal Bank Of CanadaRead the original story w/Photo

    Tuesday Jul 19 | Daily Political

    ... . Several large investors recently added to or reduced their stakes in AKRX. Creative Planning boosted its stake in Akorn by 44.1% in the second quarter. Creative Planning now owns 4,898 shares of the company's stock valued at $140,000 after buying ...

    Comment?

  15. Akorn's (AKRX) Buy Rating Reaffirmed at Royal Bank Of CanadaRead the original story w/Photo

    Monday Jul 18 | AmericanBankingNews.com

    's stock had its "buy" rating reissued by analysts at Royal Bank Of Canada in a research report issued on Monday. In other Akorn news, Director Alan D. Weinstein sold 50,000 shares of the company's stock in a transaction dated Thursday, June 2nd.

    Comment?

  16. Akorn Inc. (NASDAQ:AKRX) Receives Average Recommendation of "Buy" from BrokeragesRead the original story w/Photo

    Monday Jul 18 | AmericanBankingNews.com

    Shares of Akorn Inc. have received an average rating of "Buy" from the sixteen analysts that are presently covering the firm. Five research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company.

    Comment?

  17. Traders Sell Akorn Inc.Read the original story w/Photo

    Sunday Jul 17 | Daily Political

    Traders sold shares of Akorn Inc. on strength during trading on Friday. $3.90 million flowed into the stock on the tick-up and $13.69 million flowed out of the stock on the tick-down, for a money net flow of $9.79 million out of the stock.

    Comment?

  18. Akorn Inc. (AKRX) Shares Up 2.6%Read the original story w/Photo

    Saturday Jul 16 | Daily Political

    Akorn Inc. shares shot up 2.6% during mid-day trading on Thursday . The company traded as high as $31.13 and last traded at $31.03, with a volume of 1,049,066 shares.

    Comment?

  19. Traders Sell Shares of Akorn Inc.Read the original story w/Photo

    Friday Jul 15 | Daily Political

    Traders sold shares of Akorn Inc. on strength during trading hours on Friday. $3.90 million flowed into the stock on the tick-up and $13.69 million flowed out of the stock on the tick-down, for a money net flow of $9.79 million out of the stock.

    Comment?

  20. Loomis Sayles & Co. L P Sells 180,530 Shares of Akorn Inc.Read the original story w/Photo

    Friday Jul 15 | Daily Political

    Loomis Sayles & Co. L P reduced its stake in shares of Akorn Inc. by 48.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.

    Comment?